State Street’s Bio Green Med Solution BGMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
– Sell
-3
Closed -$3.65K – 4449
2023
Q3
$3.65K Hold
3
– – ﹤0.01% 4543
2023
Q2
$6.13K Hold
3
– – ﹤0.01% 4657
2023
Q1
$6.03K Hold
3
– – ﹤0.01% 4764
2022
Q4
$7.01K Hold
3
– – ﹤0.01% 4820
2022
Q3
$15K Hold
3
– – ﹤0.01% 4859
2022
Q2
$11K Hold
3
– – ﹤0.01% 4919
2022
Q1
$32K Hold
3
– – ﹤0.01% 4856
2021
Q4
$41K Hold
3
– – ﹤0.01% 4726
2021
Q3
$55K Buy
+3
New +$57.7K ﹤0.01% 4637

Other funds holding BGMS

State Street's BGMS Position: Q4 2023 in Review

State Street sold out of Bio Green Med Solution (BGMS) in Q4 2023, closing a stake of 3 shares — an estimated $3.65K sold.

State Street first reported a position in BGMS in Q3 2021 and held it in 9 quarters. The position peaked at $55K in Q3 2021. 7 funds tracked by Wall St. Rank hold BGMS as of Q4 2023.

  • State Street reported no remaining Bio Green Med Solution position as of Q4 2023 after selling out during the quarter.
  • State Street sold 3 Bio Green Med Solution shares in Q4 2023, an estimated $3.65K.
  • State Street first reported a position in Bio Green Med Solution in Q3 2021 and held it in 9 quarters.
  • State Street's Bio Green Med Solution position peaked at $55K in Q3 2021.
  • 7 funds tracked by Wall St. Rank held Bio Green Med Solution as of Q4 2023.

Based on State Street's 13F filing for Q4 2023, filed 14 Feb 2024.